RESUMO
Benzimidazole compounds are used in both humans and animals for controlling helminth parasites. Albendazole has teratogenic effects attributed to its active metabolite albendazole sulphoxide. The aim of this work was to evaluate the effect of the latter compound when administered to pregnant CF1 mice during the preimplantation period. Females were superovulated by intraperitoneal injection of 10 IU of eCG and 10 IU of hCG (48h later) and were paired with males of proven fertility. Albendazole sulphoxide (200 mg/kg) was orally administered by gavages at day 1, 2 or 3 of pregnancy; the control group received only the vehicle (carboxymethylcellulose). Females were killed by cervical dislocation at day 4 of pregnancy and embryos were flushed from uteri with Ham F10 media supplemented with bovine serum albumin (0.4%). Number of collected embryos per female, percentage of morphologically normal embryos, differentiation rate and number of cells per embryos were recorded. The variables were analyzed on a per litter basis by Kruskal-Wallis test. There was no effect of albendazole sulphoxide on parameters evaluated (P>0.05). We conclude that the preimplantation mouse embryo development was not significantly affected by albendazole sulphoxide.
Assuntos
Albendazol/análogos & derivados , Anti-Helmínticos/toxicidade , Blastocisto/efeitos dos fármacos , Embrião de Mamíferos/efeitos dos fármacos , Albendazol/toxicidade , Animais , Blastocisto/citologia , Embrião de Mamíferos/citologia , Feminino , Humanos , Masculino , Camundongos , Gravidez , TeratogênicosRESUMO
Benzimidazole compounds are used in both humans and animals for controlling helminth parasites. Albendazole has teratogenic effects attributed to its active metabolite albendazole sulphoxide. The aim of this work was to evaluate the effect of the latter compound when administered to pregnant CF1 mice during the preimplantation period. Females were superovulated by intraperitoneal injection of 10 IU of eCG and 10 IU of hCG (48h later) and were paired with males of proven fertility. Albendazole sulphoxide (200 mg/kg) was orally administered by gavages at day 1, 2 or 3 of pregnancy; the control group received only the vehicle (carboxymethylcellulose). Females were killed by cervical dislocation at day 4 of pregnancy and embryos were flushed from uteri with Ham F10 media supplemented with bovine serum albumin (0.4%). Number of collected embryos per female, percentage of morphologically normal embryos, differentiation rate and number of cells per embryos were recorded. The variables were analyzed on a per litter basis by Kruskal-Wallis test. There was no effect of albendazole sulphoxide on parameters evaluated (P>0.05). We conclude that the preimplantation mouse embryo development was not significantly affected by albendazole sulphoxide.
Assuntos
Humanos , Masculino , Animais , Feminino , Gravidez , Camundongos , Albendazol/análogos & derivados , Albendazol/toxicidade , Anti-Helmínticos/toxicidade , Blastocisto/citologia , Blastocisto , Embrião de Mamíferos/citologia , Embrião de Mamíferos , TeratogênicosRESUMO
In this review are cited and discussed the possible roles of growth factors on preimplantation embryo development of different species. In first term, is considered the mRNA detection in early stages of development. The distribution pattern was not uniform for the different peptides evaluated. For some of them, the mRNAs are detected at the oocyte stage and the level declines to the blastocyst stage, which suggests a maternal origin for them. For others, the level increased from 2-4 cells to blastocyst stage. On the other hand, transcripts of growth factor receptors have been detected in preimplantation embryos. This suggests that growth factors of maternal or embryo origin interact with specific receptors on preimplantation embryo surface and regulate the early development. On the other hand, culture media supplemented with different growth factors have been used to study the possible effects on in vitro development. Some investigators have found no effect. Others, however, have demonstrated changes in protein synthesis, cell number, differentiation and hatching processes. Embryo development modulation by growth factors probably involves a balance between stimulatory and inhibitory effects, although works are needed to determine the precise roles played by these polypeptides during early stages of mammalian development.(AU)
Assuntos
Humanos , Animais , Estruturas Embrionárias/embriologia , Estruturas Embrionárias/metabolismo , Substâncias de Crescimento/metabolismoRESUMO
In this review are cited and discussed the possible roles of growth factors on preimplantation embryo development of different species. In first term, is considered the mRNA detection in early stages of development. The distribution pattern was not uniform for the different peptides evaluated. For some of them, the mRNAs are detected at the oocyte stage and the level declines to the blastocyst stage, which suggests a maternal origin for them. For others, the level increased from 2-4 cells to blastocyst stage. On the other hand, transcripts of growth factor receptors have been detected in preimplantation embryos. This suggests that growth factors of maternal or embryo origin interact with specific receptors on preimplantation embryo surface and regulate the early development. On the other hand, culture media supplemented with different growth factors have been used to study the possible effects on in vitro development. Some investigators have found no effect. Others, however, have demonstrated changes in protein synthesis, cell number, differentiation and hatching processes. Embryo development modulation by growth factors probably involves a balance between stimulatory and inhibitory effects, although works are needed to determine the precise roles played by these polypeptides during early stages of mammalian development.